Insider Transactions in Q1 2022 at Dolby Laboratories, Inc. (DLB)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 09
2022
|
Mark Andrew Sherman EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,798
-3.37%
|
$138,446
$77.23 P/Share
|
Feb 08
2022
|
Micheline Chau Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+4.19%
|
-
|
Feb 08
2022
|
David Dolby |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+3.39%
|
-
|
Feb 08
2022
|
Peter C Gotcher |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+5.99%
|
-
|
Feb 08
2022
|
Tony A Prophet |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+47.97%
|
-
|
Feb 08
2022
|
Emily Rollins |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+34.67%
|
-
|
Feb 08
2022
|
Simon Segars |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+7.11%
|
-
|
Feb 08
2022
|
Roger S Siboni Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+6.9%
|
-
|
Feb 08
2022
|
Anjali Sud |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+19.27%
|
-
|
Feb 08
2022
|
Avadis Tevanian |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+50.0%
|
-
|
Feb 07
2022
|
Avadis Tevanian |
SELL
Open market or private sale
|
Indirect |
1,331
-2.5%
|
$99,825
$75.31 P/Share
|
Jan 11
2022
|
Kevin J Yeaman President and CEO |
SELL
Open market or private sale
|
Indirect |
34,621
-38.37%
|
$3,219,753
$93.11 P/Share
|
Jan 11
2022
|
Kevin J Yeaman President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
29,453
+36.52%
|
$1,237,026
$42.98 P/Share
|